Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RG-A/Texas/71/2017 (H3N2) Influenza CHIM in Healthy Adults
NCT07305207Phase 1Recruiting
- Sponsor
- Dalhousie University
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in influenza (3 arms), sponsored by Dalhousie University. Primary endpoint: Symptomatic influenza-virus infection. Started Jun 2026; status: recruiting.
02
Conditions
influenza
Beyond the preview
Go deeper on NCT07305207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07305207.